Cardiol Therapeutics (TSE: CRDL- OTCQX: CRTPF) CEO David Elsley joined Steve Darling to offer his perspective on Jazz Pharmaceuticals acquiring GW Pharma for 7.2 billion dollars. Elsley talks about what that means for the CBD Pharma industry and what it could potentially mean for Cardiol Therapeutics.
Cardiol Therapeutics sees positives for company after GW Pharma and Jazz Pharma announcement
Quick facts: Cardiol Therapeutics
Price: 4.32 CAD
Market Cap: $141.75 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Cardiol Therapeutics named herein, including the promotion by the Company of Cardiol Therapeutics in any Content on the Site, the Company...FOR OUR FULL DISCLAIMER CLICK HERE